Development
Treatment.com AI Inc.
TREIF
$0.3496
-$0.0034-0.96%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -98.49% | -98.73% | -96.59% | -95.80% | 115.29% |
| Gross Profit | 98.49% | 98.73% | 96.59% | 95.80% | -115.29% |
| SG&A Expenses | -20.47% | -80.08% | -85.39% | -92.49% | -82.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -61.55% | -85.32% | -87.05% | -92.74% | -71.60% |
| Operating Income | 61.55% | 85.32% | 87.05% | 92.74% | 71.60% |
| Income Before Tax | 59.52% | 83.94% | 86.37% | 92.32% | 71.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.52% | 83.94% | 86.37% | 92.32% | 71.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.52% | 83.94% | 86.37% | 92.32% | 71.00% |
| EBIT | 61.55% | 85.32% | 87.05% | 92.74% | 71.60% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 59.50% | 83.99% | 86.40% | 92.57% | 71.80% |
| Normalized Basic EPS | 59.60% | 84.54% | 86.49% | 92.59% | 71.80% |
| EPS Diluted | 59.50% | 83.99% | 86.40% | 92.57% | 71.80% |
| Normalized Diluted EPS | 59.60% | 84.54% | 86.49% | 92.59% | 71.80% |
| Average Basic Shares Outstanding | 0.15% | 0.19% | 0.20% | 3.45% | 2.78% |
| Average Diluted Shares Outstanding | 0.15% | 0.19% | 0.20% | 3.45% | 2.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |